Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07195097Phase 1Not yet recruiting
Phase 1, randomised trial in contraception comparing Silodosin arm with Placebo arm (2 arms). Primary endpoint: Pregnancy rate in people treated with sildosin as a male contraceptive at 3 months. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07195097.